BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11923654)

  • 1. Do panic symptoms during periods of remission predict relapse of panic disorder?
    Weisberg RB; Machan JT; Dyck IR; Keller MB
    J Nerv Ment Dis; 2002 Mar; 190(3):190-7. PubMed ID: 11923654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission and relapse in subjects with panic disorder and panic with agoraphobia: a prospective short-interval naturalistic follow-up.
    Keller MB; Yonkers KA; Warshaw MG; Pratt LA; Gollan JK; Massion AO; White K; Swartz AR; Reich J; Lavori PW
    J Nerv Ment Dis; 1994 May; 182(5):290-6. PubMed ID: 10678311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personality dimensions in panic disorder before and after effective treatment.
    Starcevic V; Uhlenhuth EH
    Anxiety; 1996; 2(2):95-8. PubMed ID: 9160608
    [No Abstract]   [Full Text] [Related]  

  • 4. Coping behavior in patients with panic disorder.
    Yamada K; Fujii I; Akiyoshi J; Nagayama H
    Psychiatry Clin Neurosci; 2004 Apr; 58(2):173-8. PubMed ID: 15009823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tranylcypromine for chronic therapy-resistant agoraphobia with panic disorder and recurrent depressive disorder].
    Boerner RJ; Lühring F
    Psychiatr Prax; 2010 Oct; 37(7):350-2. PubMed ID: 20703987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderators and mediators among panic, agoraphobia symptoms, and suicidal ideation in patients with panic disorder.
    Huang MF; Yen CF; Lung FW
    Compr Psychiatry; 2010; 51(3):243-9. PubMed ID: 20399333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phenomenology of panic attacks in panic disorder with and without agoraphobia.
    Starcevic V; Kellner R; Uhlenhuth EH; Pathak D
    Compr Psychiatry; 1993; 34(1):36-41. PubMed ID: 8425389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronicity, relapse, and illness--course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up.
    Yonkers KA; Bruce SE; Dyck IR; Keller MB
    Depress Anxiety; 2003; 17(3):173-9. PubMed ID: 12768651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Panic disorder and agoraphobia: what is effective?].
    Bandelow B; Sievert K; Röthemeyer M; Hajak G; Broocks A; Rüther E
    Fortschr Neurol Psychiatr; 1995 Nov; 63(11):451-64. PubMed ID: 8575719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional classification of anxiety-panic.
    Liebowitz MR
    Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():47-52. PubMed ID: 7902853
    [No Abstract]   [Full Text] [Related]  

  • 12. Is the course of panic disorder the same in women and men?
    Yonkers KA; Zlotnick C; Allsworth J; Warshaw M; Shea T; Keller MB
    Am J Psychiatry; 1998 May; 155(5):596-602. PubMed ID: 9585708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personality traits in early phases of panic disorder: implications on the presence of agoraphobia, clinical severity and short-term outcome.
    Carrera M; Herrán A; Ramírez ML; Ayestarán A; Sierra-Biddle D; Hoyuela F; Rodríguez-Cabo B; Vázquez-Barquero JL
    Acta Psychiatr Scand; 2006 Dec; 114(6):417-25. PubMed ID: 17087790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of past depressive episodes to symptom severity and treatment response in panic disorder with agoraphobia.
    Maddock RJ; Carter CS; Blacker KH; Beitman BD; Krishnan KR; Jefferson JW; Lewis CP; Liebowitz MR
    J Clin Psychiatry; 1993 Mar; 54(3):88-95. PubMed ID: 8468314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia.
    Mavissakalian MR; Perel JM; Talbott-Green M; Sloan C
    Biol Psychiatry; 1998 Jun; 43(11):848-54. PubMed ID: 9611676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
    Pols H; Verburg K; Hauzer R; Meijer J; Griez E
    Biol Psychiatry; 1996 Nov; 40(9):913-7. PubMed ID: 8896779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of imipramine therapy and relapse in panic disorder with agoraphobia.
    Mavissakalian MR; Perel JM
    J Clin Psychopharmacol; 2002 Jun; 22(3):294-9. PubMed ID: 12006900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Panic disorder with nocturnal panic attacks: symptoms and comorbidities.
    Sarísoy G; Böke O; Arík AC; Sahin AR
    Eur Psychiatry; 2008 Apr; 23(3):195-200. PubMed ID: 17937981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phobic symptoms as predictors of nonresponse to drug therapy in panic disorder patients (a preliminary report).
    Slaap BR; van Vliet IM; Westenberg HG; den Boer JA
    J Affect Disord; 1995 Jan; 33(1):31-8. PubMed ID: 7714306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure of phobias in panic disorder.
    Argyle N; Solyom C; Solyom L
    Br J Psychiatry; 1991 Sep; 159():378-82. PubMed ID: 1958949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.